Patent
Asparaginase-based cancer therapy (US Patent 12673092)
KYON BIOTECH AG · Granted Jul 7, 2026 · Filed May 29, 2020
Patent number: 12673092 Kind code: B2 Granted: 2026-07-07 Filed: 2020-05-29 Inventors: Slobodan Tepic (Zürich, CH); Goran Cvetkovic (Rapperswil-Jona, CH) Assignees: KYON BIOTECH AG (Zürich, CH) CPC: A61K 31/17; A61K 38/50; A61P 35/02
Abstract
The present invention relates to an improved preparation and delivery of asparaginase for use in medicine, e.g. in human and veterinary medicine.
Claims
- A method for the treatment of leukemia or lymphoma comprising administering a therapeutically effective amount of monomeric
Showing a preview — retrieve the full document via the Exa API.
Powered by the Exa API